Korea Business News Agency - NSP NEWS AGENCY.

(Seoul=NSP NEWS AGENCY) = Samsung Electronics participates as a strategic investor in a U.S. DNA analysis equipment company.

Samsung Electronics announced on the 12th that it participated in the $277 million (approximately KRW 380.4 billion) Series D investment recently attracted by Element Biosciences. Many companies, including Samsung Electronics, participated in this investment.

Through this investment, Element will be able to utilize Samsung Electronics’ AI/IT technology to further improve DNA sequencing accuracy and lower costs, enabling various business synergies in the field of future data-driven precision medicine research.

Samsung Electronics plans to explore new business opportunities in areas ranging from medical devices to digital health by combining its AI capabilities, medical devices, and digital health technologies with Element’s DNA analysis technology.

By Soon-ki Lee(s8789@nspna.com) and Jeonghwa Choi(choijh@nspna.com)

ⓒNSP News Agency·NSP TV. All rights reserved. Prohibits using to train AI models.